Live Breaking News & Updates on Quarter for recursion pharmaceuticals

Stay informed with the latest breaking news from Quarter for recursion pharmaceuticals on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Quarter for recursion pharmaceuticals and stay connected to the pulse of your community

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Director Sells $87,684.02 in Stock

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) Director Blake Borgeson sold 11,447 shares of the stock in a transaction on Tuesday, April 16th. The shares were sold at an average price of $7.66, for a total transaction of $87,684.02. Following the completion of the sale, the director now directly owns 7,229,861 shares in the […]

Canada , China , Blake-borgeson , First-horizon-advisors-inc , Nasdaq , Quarter-for-recursion-pharmaceuticals , Recursion-pharmaceuticals-stock-performance , Recursion-pharmaceuticals , Needham-company , National-bank , Securities-exchange-commission , China-universal-asset-management-co

Cherry Creek Investment Advisors Inc. Acquires Shares of 17,853 Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)

Cherry Creek Investment Advisors Inc. bought a new stake in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) in the 4th quarter, according to its most recent filing with the SEC. The fund bought 17,853 shares of the company’s stock, valued at approximately $176,000. Other large investors have also recently made changes to their positions in […]

China , Tina-marriott-larson , Christopher-gibson , Recursion-pharmaceuticals , Cherry-creek-investment-advisors-inc , Recursion-pharmaceuticals-inc , Advisor-group , Baldwin-brothers , Insider-transactions-at-recursion-pharmaceuticals , Recursion-pharmaceuticals-company-profile , Recursion-pharmaceuticals-stock-down , Quarter-for-recursion-pharmaceuticals

Insider Selling: Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) COO Sells $86,000.00 in Stock

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) COO Tina Marriott sold 8,000 shares of the company’s stock in a transaction on Thursday, March 21st. The shares were sold at an average price of $10.75, for a total value of $86,000.00. Following the completion of the sale, the chief operating officer now directly owns 639,982 […]

Tina-marriott , Institutional-investors-weigh-in-on-recursion-pharmaceuticals , Recursion-pharmaceuticals-stock-performance , News-ratings-for-recursion-pharmaceuticals-daily , Keycorp , Quarter-for-recursion-pharmaceuticals , Needham-company , Vanguard-group-inc , Recursion-pharmaceuticals , Mubadala-investment-co , Goldman-sachs-group-inc , Securities-exchange-commission

Tina Marriott Sells 8,000 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Stock

Tina Marriott Sells 8,000 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

China , Canada , Tina-marriott , First-horizon-advisors-inc , Recursion-pharmaceuticals-trading-down , Securities-exchange-commission , Recursion-pharmaceuticals-inc , Quarter-for-recursion-pharmaceuticals , News-ratings-for-recursion-pharmaceuticals-daily , Keycorp , Comerica-bank , Recursion-pharmaceuticals-company-profile

Insider Selling: Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) CEO Sells $430,743.34 in Stock

Insider Selling: Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) CEO Sells $430,743.34 in Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Canada , Christopher-gibson , Quarter-for-recursion-pharmaceuticals , News-ratings-for-recursion-pharmaceuticals-daily , Recursion-pharmaceuticals-inc , Recursion-pharmaceuticals , Nasdaq , Principal-financial-group-inc , Baldwin-brothers , Ameritas-investment-partners-inc , Recursion-pharmaceuticals-company-profile , Recursion-pharmaceuticals-stock-performance

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) COO Tina Marriott Sells 8,000 Shares

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) COO Tina Marriott sold 8,000 shares of the firm’s stock in a transaction on Thursday, February 22nd. The shares were sold at an average price of $14.89, for a total value of $119,120.00. Following the completion of the sale, the chief operating officer now owns 639,982 shares […]

China , Canada , Tina-marriott , Recursion-pharmaceuticals-stock-performance , Needham-company , Quarter-for-recursion-pharmaceuticals , Comerica-bank , Recursion-pharmaceuticals , China-universal-asset-management-co , Securities-exchange-commission , Recursion-pharmaceuticals-inc , News-ratings-for-recursion-pharmaceuticals-daily

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Position Reduced by Baillie Gifford & Co.

Baillie Gifford & Co. lowered its stake in shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 2.2% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 24,551,409 shares of the company’s stock after selling 546,221 shares during the period. Baillie Gifford & Co. owned approximately 11.39% […]

Christopher-gibson , Tina-marriott-larson , Securities-exchange-commission , Needham-company , Recursion-pharmaceuticals-inc , Recursion-pharmaceuticals , Recursion-pharmaceuticals-stock-performance , Nasdaq , Quarter-for-recursion-pharmaceuticals , Norges-bank , Blackrock-inc , Jpmorgan-chase-co

Baillie Gifford & Co. Trims Stock Position in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)

Baillie Gifford & Co. lowered its holdings in shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 2.2% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 24,551,409 shares of the company’s stock after selling 546,221 shares during the quarter. Baillie Gifford & […]

Blake-borgeson , Christopher-gibson , Securities-exchange-commission , Recursion-pharmaceuticals-price-performance , Needham-company , Recursion-pharmaceuticals-inc , Recursion-pharmaceuticals , Quarter-for-recursion-pharmaceuticals , Nasdaq , Norges-bank , Blackrock-inc , Jpmorgan-chase-co

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Position Reduced by Baillie Gifford & Co.

Baillie Gifford & Co. lowered its stake in shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 2.2% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 24,551,409 shares of the company’s stock after selling 546,221 shares during the period. Baillie Gifford & Co. owned approximately 11.39% […]

Christopher-gibson , Tina-marriott-larson , Jpmorgan-chase-co , News-ratings-for-recursion-pharmaceuticals-daily , Baillie-gifford-co , Recursion-pharmaceuticals-company-profile , Sumitomo-mitsui-trust-holdings-inc , Investment-management , Needham-company , Recursion-pharmaceuticals , Recursion-pharmaceuticals-inc , Securities-exchange-commission

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Director Sells $106,457.10 in Stock

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Director Sells $106,457.10 in Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Blake-borgeson , Securities-exchange-commission , Sumitomo-mitsui-trust-holdings-inc , Nasdaq , Investment-management , Needham-company , Recursion-pharmaceuticals-stock-performance , Recursion-pharmaceuticals , Recursion-pharmaceuticals-inc , Jpmorgan-chase-co , News-ratings-for-recursion-pharmaceuticals-daily , Recursion-pharmaceuticals-company-profile